Xin C et al. |
FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism. |
2007 |
Br. J. Pharmacol. |
pmid:17325654
|
Ishihara K et al. |
Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils. |
2004 |
Br. J. Pharmacol. |
pmid:15210580
|
Chen CZ et al. |
The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. |
2009 |
Br. J. Pharmacol. |
pmid:19785660
|
Hoshimoto A et al. |
Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. |
2002 |
Br. J. Pharmacol. |
pmid:12010777
|
Gaub P et al. |
The histone acetyltransferase p300 promotes intrinsic axonal regeneration. |
2011 |
Brain |
pmid:21705428
|
Li KK et al. |
MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). |
2013 |
Brain Pathol. |
pmid:23227829
|
Li KK et al. |
MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L. |
2013 |
Brain Pathol. |
pmid:23252729
|
Lin YC et al. |
Effects of trichostatin A on neuronal mu-opioid receptor gene expression. |
2008 |
Brain Res. |
pmid:18950606
|
Suzuki-Mizushima Y et al. |
Enhancement of NGF- and cholera toxin-induced neurite outgrowth by butyrate in PC12 cells. |
2002 |
Brain Res. |
pmid:12270499
|
Sano M and Kitajima S |
Inhibition of the nerve growth factor-induced outgrowth of neurites by trichostatin A requires protein synthesis de novo in PC12D cells. |
1996 |
Brain Res. |
pmid:9117395
|
Wei L et al. |
Microinjection of histone deacetylase inhibitor into the ventrolateral orbital cortex potentiates morphine induced behavioral sensitization. |
2016 |
Brain Res. |
pmid:27312092
|
Hou X et al. |
HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring μ-opioid receptor in spinal cord. |
2017 |
Brain Res. |
pmid:28559159
|
Sharifulina SA et al. |
Epigenetic regulation of death of crayfish glial cells but not neurons induced by photodynamic impact. |
2014 |
Brain Res. Bull. |
pmid:24502940
|
Niu F et al. |
Trichostatin A enhances OGD-astrocyte viability by inhibiting inflammatory reaction mediated by NF-kappaB. |
2009 |
Brain Res. Bull. |
pmid:19103266
|
Sakharkar AJ et al. |
A role for histone acetylation mechanisms in adolescent alcohol exposure-induced deficits in hippocampal brain-derived neurotrophic factor expression and neurogenesis markers in adulthood. |
2016 |
Brain Struct Funct |
pmid:26941165
|
Sawa H et al. |
Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells. |
2002 |
Brain Tumor Pathol |
pmid:12622137
|
Sawa H et al. |
Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad. |
2001 |
Brain Tumor Pathol |
pmid:11908866
|
Zych J et al. |
The epigenetic modifiers 5-aza-2'-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells. |
2013 |
Braz. J. Med. Biol. Res. |
pmid:23797495
|
Kim SH et al. |
Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein. |
2010 |
Breast Cancer Res. |
pmid:20388208
|
Xu J et al. |
CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. |
2010 |
Breast Cancer Res. Treat. |
pmid:19466541
|
Motevalli A et al. |
The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines. |
2014 |
Breast Cancer Res. Treat. |
pmid:24807106
|
Domingo-Domènech J et al. |
Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells. |
2008 |
Breast Cancer Res. Treat. |
pmid:18064564
|
Huang KT et al. |
Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer. |
2011 |
Breast Cancer Res. Treat. |
pmid:21755341
|
Pryzbylkowski P et al. |
Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR. |
2008 |
Breast Cancer Res. Treat. |
pmid:17891453
|
Auer D et al. |
Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer. |
2009 |
Breast Cancer Res. Treat. |
pmid:18618240
|
Guo W et al. |
Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma. |
2014 |
Cancer |
pmid:24798237
|
Pan L et al. |
Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. |
2007 |
Cancer |
pmid:17330857
|
Tan L et al. |
Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells. |
2011 |
Cancer |
pmid:20925046
|
Chen MY et al. |
Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. |
2011 |
Cancer |
pmid:21491416
|
Kim MK and Carroll WL |
Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2. |
2004 |
Cancer |
pmid:15382088
|
El-Awady RA et al. |
Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy. |
2015 |
Cancer Biol. Ther. |
pmid:25962089
|
Lo PK et al. |
Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. |
2006 |
Cancer Biol. Ther. |
pmid:16410723
|
Taghiyev AF et al. |
TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome. |
2006 |
Cancer Biol. Ther. |
pmid:17110788
|
David GL et al. |
MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine. |
2004 |
Cancer Biol. Ther. |
pmid:15034303
|
Sangster-Guity N et al. |
Molecular profiling of embryonal carcinoma cells following retinoic acid or histone deacetylase inhibitor treatment. |
2004 |
Cancer Biol. Ther. |
pmid:15467438
|
Song K et al. |
Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1, a novel epithelial-mesenchymal transition inducer in pancreatic cancer. |
2011 |
Cancer Biol. Ther. |
pmid:21709440
|
Karagiannis TC et al. |
The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X. |
2005 |
Cancer Biol. Ther. |
pmid:16082178
|
Mazzarelli P et al. |
Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation? |
2007 |
Cancer Biol. Ther. |
pmid:18253084
|
Keen JC et al. |
Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells. |
2004 |
Cancer Biol. Ther. |
pmid:15662126
|
Ranganathan P and Rangnekar VM |
Exploiting the TSA connections to overcome apoptosis-resistance. |
2005 |
Cancer Biol. Ther. |
pmid:15908800
|
Taghiyev AF et al. |
Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment. |
2005 |
Cancer Biol. Ther. |
pmid:15846101
|
Chatterjee N et al. |
Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells. |
2013 |
Cancer Biol. Ther. |
pmid:23792638
|
Anantharaju PG et al. |
Naturally occurring benzoic acid derivatives retard cancer cell growth by inhibiting histone deacetylases (HDAC). |
2017 |
Cancer Biol. Ther. |
pmid:28506198
|
Chakravarty G et al. |
Cytoplasmic compartmentalization of SOX9 abrogates the growth arrest response of breast cancer cells that can be rescued by trichostatin A treatment. |
2011 |
Cancer Biol. Ther. |
pmid:21084857
|
Honda H et al. |
Regulation of the CLDN3 gene in ovarian cancer cells. |
2007 |
Cancer Biol. Ther. |
pmid:17986852
|
Zhang XH et al. |
Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer. |
2008 |
Cancer Biol. Ther. |
pmid:18708766
|
Zhang F et al. |
Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells. |
2009 |
Cancer Biol. Ther. |
pmid:19270532
|
Dowling M et al. |
Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents. |
2005 |
Cancer Biol. Ther. |
pmid:15753652
|
Tang X et al. |
Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. |
2012-2013 |
Cancer Biomark |
pmid:23321465
|
Trtková K et al. |
Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor. |
2010 |
Cancer Biomark |
pmid:21178266
|